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The fırst restriction enzyme, an endonuclease capable of cutting double-stranded DNA in a site-specifıc fashion, was isolated from Escherichia coli in 1968. Four decades later, researchers identifıed another system for cleaving foreign DNA-one that acts as an adaptive immune system. Conferred by clustered, regularly interspaced, short palindromic repeats (CRISPR) and a set of CRISPR-associated genes (cas), CRISPRCas systems differ from restriction-modifıcation systems primarily in that they can readily acquire new specifıcity.
Within bacterial cells, restriction enzymes destroy invasive DNA from foreign sources. Their discovery arose from the observation that phages could rapidly gain or lose the ability to infect certain bacterial hosts, depending on the strain on which they were propagated (Fig. 1) . These viruses had acquired properties from the host, known as host-controlled modifıcation, in which the phage genomic DNA is changed in such a way as to render the specifıc sites that restriction enzymes ordinarily target unrecognizable. A bacterial strain containing such a modifıcation system thus protects its own DNA from a restriction enzyme, and can safely use that enzyme to eliminate invading phage DNA. A phage successfully replicating in a host with the modifıcation system would acquire this immunity (see box, p. 206). Taken as a whole, these restriction and modifıca-tion (R-M) systems also form a type of prokaryotic immune system, one that distinguishes self from nonself genetic elements, destroying the latter.
Main Components of CRISPR-Cas Systems
Unlike R-M systems, CRISPRs were fırst identifıed not by their activity but as distinctive elements in genomic sequences. They are defıned as a series of palindromic repeats (24 -47 bp long) interspaced with similarly sized "spacers" of DNA, many of which appear to be derived from phage or plasmid sequences (Fig. 2) . They are typically found alongside a set of conserved cas genes. CRISPRs are found in approximately half of completed bacterial genomes, and in more than 90% of archaeal genomes. A publically available tool (http://crispr.u-psud.fr/crispr/) can help identify CRISPRs in microbes of interest.
Two decades after being identifıed in bacterial genome sequences, researchers found that CRISPRs function in host immunity. For example, after phages infect Streptococcus thermophilus bacteria, which are used to make cheese and yogurt, most cells will die but surviving bacterial colonies contain a new repeat-spacer unit in their CRISPR-arrays. Although the new repeat (36 nt) is identical to previous repeats in the array, the new spacer sequence (30 nt) perfectly matches a phage genomic sequence. Furthermore, different phage-resistant colonies acquire different spacers, each corresponding to some region of the genome of the infecting phage.
Subsequently, researchers isolated mutant "escape" phages capable of infecting bacteria that should be protected by their CRISPR-arrays. Genome analyses of these phages revealed single point mutations in the phage sequence targeted by the spacer, and these single point mutations were suffıcient to bypass conferred immunity.
CRISPR-Cas systems are also effective against other foreign DNA, impeding conjugation and transformation of plasmids bearing sequences present in the repeat-spacer array.
How the CRISPR-Cas System Works
Discovery of a CRISPR-Cas function led to a flurry of research to decipher its mode of action and harness its potential. CRISPR-Cas systems confer immunity in three steps: (1) new spacers are acquired, the adaptation/immunization stage; (2) those spacers are transcribed into small RNAs to become capable of targeting foreign elements, or the maturation stage; and (3) foreign elements are cleaved during the interference stage (Fig. 3) . To date, CRISPR-Cas systems cleave doublestranded DNA and, in one case, single-stranded RNA in vitro.
The action most readily comparable to that of restriction enzymes is conferred by the "interference" step. A Cas protein or a complex of Cas proteins acts as an endonuclease, cleaving the foreign genetic material in a sequence-specifıc manner. Unlike a restriction enzyme, however, the specifıcity is conferred not by a protein, but rather by a short CRISPR RNA (crRNA) derived from the repeat-spacer array and generated during the maturation step. The "nonself " or foreign nucleotide region targeted by this spacer-derived crRNA is known as the proto-spacer, and a single mismatched base in the proto-spacer can be enough to bypass the highly specifıc targeting of crRNA.
Because at least one perfect copy of the protospacer sequence is in the host genome, the spacer itself, an additional specifıcity marker is needed to avoid restriction of the host's own DNA. The cleavage of the proto-spacer within the invading nucleic acids depends on the presence of a short (2-5 nt) recognition motif next to the protospacer, known as a proto-spacer adjacent motif (PAM), which is absent in the host repeat-spacer array. However, this specifıcity is not universal, as type III CRISPR-Cas systems lack any recognizable PAMs. In addition, it appears that in the repeat-spacer array, the crRNA binds the repeats flanking the spacer, thus preventing crRNA mediated-targeting.
The maturation step produces these targeting crRNA molecules from the repeat-spacer array (Fig. 3B ). It can vary from transcribing the entire repeat-spacer array (containing multiple repeatspacers in tandem) and then processing the RNA into shorter fragments, as in S. thermophilus, to individual transcription of single repeat-spacerrepeat RNAs, each from their own promoter, as in Neisseria meningiditis. In both cases, the short RNA generated is processed by one or more pro- Host-controlled modification. A phage grown on a permissive strain can replicate on a permissive (restriction-modification negative) or modifying (restriction negative, modification positive) strain, but not on a restrictive strain (restriction and modification positive). However, once replicated in a modifying strain, the phage gains the ability to successfully infect a restrictive strain.
tein-mediated cleavage events per molecule. This processing can be mediated by Cas proteins as well as by other host factors such as RNAse III. The result is a series of short crRNAs containing the entirety or part of a spacer, flanked on at least one side by a repeat-derived sequence.
Adaptation Step Is Not Well Understood
The fırst step, the adaptation (Fig. 3A) , is what truly sets CRISPR-Cas and R-M systems apart. Through this process, a CRISPR array adapts to its host's genetic environment and, upon expo-
FIGURE 2
Anatomy of a (Type II) CRISPR-Cas locus. The CRISPR-Cas locus encoded by the microbial cell (top) includes a cluster of CRISPR-associated (cas) genes followed by a repeat-spacer array of palindromic repeat sequences flanking at least one spacer, which is typically homologous to a sequence on a foreign DNA element. In the scenario depicted, one spacer is identical to a region in the phage genome (bottom), termed the proto-spacer. Beside the targeted region is a proto-spacer adjacent motif (PAM) required for CRISPR activity.
Avoiding RM Systems
Bacteriophages have several ways to avoid RM systems, which include: 1) taking advantage of host modifıcation systems (e.g., methylation) to mask restriction sites in their own DNA (see Fig. 1 ); 2) encoding their own modifıcation system to mask restriction sites; 3) substituting modifıed nucleotides (e.g., hydroxymethylcytosine replaces cytosine in phage T4) in their genome to mask restriction sites; 4) using proteins that bind to and mask restriction sites in the phage; 5) encoding proteins that interfere with the host restriction enzymes; and 6) eliminating recognition sites from their genome, so the restriction enzymes have no target.
Avoiding CRISPR Systems
Bacteriophages can avoid or bypass the immunity conferred by a CRISPR-Cas system, but the fıeld of CRISPR avoidance is still in its infancy. The most obvious way to avoid a CRISPR system is to modify a base within the proto-spacer or PAM to evade specifıc recognition. This occurs regularly in phage-host challenges where CRISPR immunity is involved. A set of genes found in Pseudomonas phages encode proteins interfering with the CRISPR-Cas system. These anti-CRISPR genes appear to act on the interference mechanism but not the adaptation or maturation steps. sure to foreign elements, confers new immunities on the host. However, the acquisition of new spacers is the least-understood aspect of CRISPR biology. While natural bacterial and archaeal populations show clear divergence at CRISPR loci, suggestive of regular spacer acquisitions, and CRISPR arrays can be manipulated through traditional genetic means (using restriction enzymes) to incorporate new spacers, only a handful of microbial species have acquired spacers in the lab.
The spacer content of CRISPRs, alongside studies showing no strong strand bias of acquisitions, suggests spacers are being acquired from DNA targets. The Cas1 protein, which is essential for acquisition, appears to cleave both single-and double-stranded DNA into shorter fragments, presumably before incorporating them into the repeat-spacer array.
Where spacer acquisition has been observed, the only apparent sequence requirement is, where relevant, having the PAM alongside the proto-spacer. With the PAM typically required for subsequent cleavage by the Cas protein/ crRNA complex, this specifıcity at the acquisition step is intuitive, although the mechanism for it is unknown. In the majority of cases, the new spacer is acquired at the 5Ј end of the repeat-spacer array and a repeat is added to flank the new spacer. A few CRISPR-Cas systems show evidence of priming, where adding a single spacer primes the system to acquire more spacers targeting the same strand of that DNA molecule, even when the fırst spacer is not a perfect match and, therefore, does not confer immunity. This process might provide a means for preventing escape phage that carry mutations in a proto-spacer from bypassing CRISPR-based immunity.
One puzzling question is whether, or how, the system discriminates between self and nonself DNA. A laboratory experiment with an inducible CRISPR-Cas system containing spacers targeting host genes demonstrated that, once a self-spacer is acquired, it can target and kill the host. Selfrecognition, if it occurs, must occur at the level of acquisition. To date there is no evidence of any host-controlled modifıcation, like that defıning R-M systems, involved in CRISPR acquisition. The only known selection in acquisition appears to be the requirement for PAMs, which are far too short to be avoided in the host genome. In fact, PAMs do not appear to be underrepresented in CRISPR-containing genomes. While spacer acquisition might be a rare and regulated event as likely to target the host as not, the selective pressure to maintain such a system would have to be enormous.
CRISPR-Cas and R-M Systems Working Together
The CRISPR-Cas and R-M systems appear to play analogous roles in bacterial immunity and are present together in many species. When a well-characterized R-M system was introduced into a CRISPR-containing strain of S. thermophilus, the two systems did not conflict but worked together to confer a greater resistance to a targeted phage. When invading DNA was modifıed to protect it from the restriction system, it had no effect on either spacer acquisition or CRISPRmediated interference.
The two systems also work together as a powerful tool for genome editing (Fig. 4) . Because mature crRNA and Cas9 are the only required components for such editing, the two can be introduced together on a vector, even in eukaryotes, and result in targeted cleavage. Simply choose a desired cleavage site adjacent to a PAM and design an oligomer that, when transcribed, results in a mature cRNA targeting that genomic region. Clone the oligomer, using restriction enzymes, into a Cas9-containing expression vector, and introduce the vector into the cells whose
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The Future of CRISPRs
Along with their parallels to R-M systems, CRISPR-Cas systems offer several new opportunities. First, from the point of view of a bacterial immune system, CRISPRs are adaptive and the array becomes, effectively, a memory of past encounters with foreign DNA. Sequencing and monitoring CRISPR arrays provides valuable strain tracking markers, and perhaps even a record of invaders the strain has encountered.
Second, since a single CRISPR array can be made to target any sequence adjacent to a specifıc PAM by adding an associated spacer, CRISPRs can be engineered to create new plasmid-or phage-resistant bacterial strains. Spacers or crRNAs can be generated at will to result in a one-size-fıts-all restriction system capable of cleaving any known sequence with extremely high specifıcity. This can be a tremendous tool for editing genomes. Although restriction enzymes are the workhorses of molecular biology, CRISPRs expand our toolbox considerably.
